We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Pathology

Image: VENTANA DP 600 slide scanner (Photo courtesy of Roche Diagnostics)

Next-Gen, High-Capacity Slide Scanner for Digital Pathology to Help Diagnose Cancer

A new, high-capacity slide scanner creates high-resolution, digital images of stained tissue samples that help to diagnose cancer and determine a patient’s treatment. More...
29 Jun 2022
Image: Neuronal marker positivity in the middle frontal and inferior temporal gyrus of human post-mortem brains with common tauopathies (Photo courtesy of University of California San Francisco)

Caspase-6-Cleaved Tau is Relevant in Alzheimer's Disease

Alzheimer’s disease (AD) is characterized by the formation of aggregates of the tau protein in brain cells called neurofibrillary tangles. Although deposits of the amyloid β-protein are also found in AD brains, some scientists think that the tau protein aggregates are primarily responsible for the development of AD. More...
27 Jun 2022
Image: Colonic biopsy with features of collagenous colitis. Trichrome stain highlights irregular subepithelial collagen with entrapment of capillaries and inflammatory cells (Photo courtesy of Catherine E. Hagen, MD)

Appendectomy Linked to Higher Risk of Microscopic Colitis

The most common symptom of microscopic colitis is chronic, watery, non-bloody diarrhea. Episodes of diarrhea can last for weeks, months, or even years. However, many people with microscopic colitis may have long periods without diarrhea. More...
23 Jun 2022
Image: Scientists blend AI and 3D tissue imaging to identify aggressive prostate cancer (Photo courtesy of Pexels)

AI-3D Collaboration to Provide Never-Before-Seen View and Understanding of Prostate Cancer Cells

Researchers expect to gain valuable new insights into highly aggressive prostate cancer by combining Artificial Intelligence (AI)-powered diagnostic imaging with three-dimensional (3D) tissue imaging. More...
23 Jun 2022
Image: SARS-CoV-2 ddPCR Kit is a partition-based endpoint RT-PCR test for the qualitative detection of nucleic acids from SARS-CoV-2 (Photo courtesy of Thermo Fisher Scientific)

SARS-Cov-2 RNA Detected in FFPE Tissue by Droplet Digital PCR

SARS-CoV-2 infection can result in diverse, multiorgan pathology, the most significant being in the lungs, heart, kidney, central nervous system, liver, lymph nodes, bone marrow, vasculature, intestine, and placenta. More...
22 Jun 2022
Image: Galen Gastric assists pathologists in improving gastric cancer detection (Photo courtesy of Ibex Medical)

World's First AI-Powered Solution for Gastric Cancer Detection

A first-of-its-kind artificial intelligence (AI)-powered solution supports pathologists in the detection of various types of gastric cancer. More...
17 Jun 2022
Image: Histopathology of hormone receptor–positive (HR+) breast cancer (Photo courtesy of Emily S. Reisenbichler, MD)

Liquid Biopsy Identifies Breast Cancer Patients Destined to Recur

Breast cancer is the most commonly diagnosed cancer worldwide. Most breast cancers, nearly 80%, are hormone receptor–positive (HR+). Unlike other subtypes of breast cancers in which risk of recurrence decreases 5 years after diagnosis, the recurrence risk for HR+ breast cancer remains steady from 5 years to at least 20 years with some patients experiencing recurrence three decades after diagnosis. More...
15 Jun 2022
Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ESR Analyzer
miniiSED™


The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.
Copyright © 2000-2025 Globetech Media. All rights reserved.